1.Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem. 1991. 37:2029–37.
Article
2.Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem. 2001. 47:13–27.
Article
3.Bergstrom JP., Helander A. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol. 2008. 43:436–41.
Article
4.Delanghe JR., Helander A., Wielders JP., Pekelharing JM., Roth HJ., Schellenberg F, et al. Development and multicenter evaluation of the N latex CDT direct immunonephelometric assay for serum carbohydrate-deficient transferrin. Clin Chem. 2007. 53:1115–21.
Article
5.Helander A., Husa A., Jeppsson JO. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem. 2003. 49:1881–90.
Article
6.Stibler H., Kjellin KG. Isoelectric focusing and electrophoresis of the CSF proteins in tremor of different origins. J Neurol Sci. 1976. 30:269–85.
Article
7.Helander A., Carlsson S. Carbohydrate-deficient transferrin and gamma-glutamyl transferase levels during disulfiram therapy. Alcohol Clin Exp Res. 1996. 20:1202–5.
Article
8.Jeppsson JO., Kristensson H., Fimiani C. Carbohydrate-deficient transferrin quantified by HPLC to determine heavy consumption of alcohol. Clin Chem. 1993. 39:2115–20.
Article
9.Dibbelt L. Does trisialo-transferrin provide valuable information for the laboratory diagnosis of chronically increased alcohol consumption by determination of carbohydrate-deficient transferrin? Clin Chem. 2000. 46:1203–5.
Article
10.Jeppsson JO., Arndt T., Schellenberg F., Wielders JP., Anton RF., Whitfield JB, et al. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med. 2007. 45:558–62.
Article
11.Schellenberg F., Girre C., Nalpas B., Plat A., Tome A., Pages JC. Analytical evaluation of a new capillary electrophoresis method for carbohydrate-deficient transferrin measurement. Clin Chim Acta. 2007. 382:48–53.
Article
12.Schellenberg F., Mennetrey L., Girre C., Nalpas B., Pages JC. Automated measurement of carbohydrate-deficient transferrin using the Bio-Rad %CDT by the HPLC test on a Variant HPLC system: evaluation and comparison with other routine procedures. Alcohol Alcohol. 2008. 43:569–76.
13.Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods: approved guideline EP5-A2. Wayne, PA: Clinical and Laboratory Standards Institute;2004.
14.Wuyts B., Delanghe JR., Kasvosve I., Wauters A., Neels H., Janssens J. Determination of carbohydrate-deficient transferrin using capillary zone electrophoresis. Clin Chem. 2001. 47:247–55.
Article
15.Arndt T., Hackler R., Kleine TO., Gressner AM. Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay. Clin Chem. 1998. 44:27–34.
Article
16.Hackler R., Arndt T., Helwig-Rolig A., Kropf J., Steinmetz A., Schaefer JR. Investigation by isoelectric focusing of the initial carbohydrate-deficient transferrin (CDT) and non-CDT transferrin isoform fractionation step involved in determination of CDT by the ChronAlcoI.D. assay. Clin Chem. 2000. 46:483–92.
Article
17.Lanz C., Kuhn M., Deiss V., Thormann W. Improved capillary electrophoresis method for the determination of carbohydrate-deficient transferrin in patient sera. Electrophoresis. 2004. 25:2309–18.
Article
18.Legros FJ., Nuyens V., Minet E., Emonts P., Boudjeltia KZ., Courbe A, et al. Carbohydrate-deficient transferrin isoforms measured by capillary zone electrophoresis for detection of alcohol abuse. Clin Chem. 2002. 48:2177–86.
Article
19.Fleming MF., Anton RF., Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res. 2004. 28:1347–55.
Article
20.Scouller K., Conigrave KM., Macaskill P., Irwig L., Whitfield JB. Should we use carbohydrate-deficient transferrin instead of gamma-glutamyltransferase for detecting problem drinkers? A systematic review and metaanalysis. Clin Chem. 2000. 46:1894–902.
21.Imbert-Bismut F., Naveau S., Morra R., Munteanu M., Ratziu V., Abella A, et al. The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption. Eur J Gastroenterol Hepatol. 2009. 21:18–27.
Article
22.Bergstrom JP., Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta. 2008. 388:59–67.
23.Lieber CS. Carbohydrate deficient transferrin in alcoholic liver disease: mechanisms and clinical implications. Alcohol. 1999. 19:249–54.
24.Nalpas B., Hispard E., Thepot V., Pot S., Dally S., Berthelot P. A comparative study between carbohydrate-deficient transferrin and gamma-glutamyltransferase for the diagnosis of excessive drinking in a liver unit. J Hepatol. 1997. 27:1003–8.
Article